Emerging therapy-related kidney disease

Lois J Arend, Tibor Nadasdy

Research output: Contribution to journalArticle

Abstract

Context.-Many new therapies have emerged within the last 5 to 10 years to treat a variety of conditions. Several of these have direct or indirect renal toxicities that may go undiagnosed without careful attention of the pathologist to a patient's clinical history, particularly the addition of new medications or treatments. Objective.-To discuss patterns of renal injury resulting from medications or therapeutic regimens that have been introduced within the last 10 years. Recognition of these patterns may allow the pathologist to alert the attending clinician to a possible drug-induced renal injury and prevent further deterioration of renal function and possible chronic kidney disease. Data Sources.-A review of recent literature and unpublished observations of case-derived material. Conclusions.-A number of newer therapies have emerged as agents of renal toxicity, producing a variety of pathologic changes in the kidney. The outcome can be acute or chronic glomerular, tubular, interstitial, and/or vascular injury. Some drugs will result in irreversible changes and end-stage renal disease, whereas many of the alterations can be reversed with removal of the offending agent, avoiding potential long-term kidney injury. (Arch Pathol Lab Med. 2009; 133:268-278).

Original languageEnglish (US)
Pages (from-to)268-278
Number of pages11
JournalArchives of Pathology and Laboratory Medicine
Volume133
Issue number2
StatePublished - Feb 2009

Fingerprint

Kidney Diseases
Kidney
Wounds and Injuries
Therapeutics
Renal Agents
Information Storage and Retrieval
Vascular System Injuries
Chronic Renal Insufficiency
Pharmaceutical Preparations
Chronic Kidney Failure

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Medical Laboratory Technology

Cite this

Emerging therapy-related kidney disease. / Arend, Lois J; Nadasdy, Tibor.

In: Archives of Pathology and Laboratory Medicine, Vol. 133, No. 2, 02.2009, p. 268-278.

Research output: Contribution to journalArticle

Arend, Lois J ; Nadasdy, Tibor. / Emerging therapy-related kidney disease. In: Archives of Pathology and Laboratory Medicine. 2009 ; Vol. 133, No. 2. pp. 268-278.
@article{f362464e3410445c8ef26c89b2818eb3,
title = "Emerging therapy-related kidney disease",
abstract = "Context.-Many new therapies have emerged within the last 5 to 10 years to treat a variety of conditions. Several of these have direct or indirect renal toxicities that may go undiagnosed without careful attention of the pathologist to a patient's clinical history, particularly the addition of new medications or treatments. Objective.-To discuss patterns of renal injury resulting from medications or therapeutic regimens that have been introduced within the last 10 years. Recognition of these patterns may allow the pathologist to alert the attending clinician to a possible drug-induced renal injury and prevent further deterioration of renal function and possible chronic kidney disease. Data Sources.-A review of recent literature and unpublished observations of case-derived material. Conclusions.-A number of newer therapies have emerged as agents of renal toxicity, producing a variety of pathologic changes in the kidney. The outcome can be acute or chronic glomerular, tubular, interstitial, and/or vascular injury. Some drugs will result in irreversible changes and end-stage renal disease, whereas many of the alterations can be reversed with removal of the offending agent, avoiding potential long-term kidney injury. (Arch Pathol Lab Med. 2009; 133:268-278).",
author = "Arend, {Lois J} and Tibor Nadasdy",
year = "2009",
month = "2",
language = "English (US)",
volume = "133",
pages = "268--278",
journal = "Archives of Pathology and Laboratory Medicine",
issn = "0003-9985",
publisher = "College of American Pathologists",
number = "2",

}

TY - JOUR

T1 - Emerging therapy-related kidney disease

AU - Arend, Lois J

AU - Nadasdy, Tibor

PY - 2009/2

Y1 - 2009/2

N2 - Context.-Many new therapies have emerged within the last 5 to 10 years to treat a variety of conditions. Several of these have direct or indirect renal toxicities that may go undiagnosed without careful attention of the pathologist to a patient's clinical history, particularly the addition of new medications or treatments. Objective.-To discuss patterns of renal injury resulting from medications or therapeutic regimens that have been introduced within the last 10 years. Recognition of these patterns may allow the pathologist to alert the attending clinician to a possible drug-induced renal injury and prevent further deterioration of renal function and possible chronic kidney disease. Data Sources.-A review of recent literature and unpublished observations of case-derived material. Conclusions.-A number of newer therapies have emerged as agents of renal toxicity, producing a variety of pathologic changes in the kidney. The outcome can be acute or chronic glomerular, tubular, interstitial, and/or vascular injury. Some drugs will result in irreversible changes and end-stage renal disease, whereas many of the alterations can be reversed with removal of the offending agent, avoiding potential long-term kidney injury. (Arch Pathol Lab Med. 2009; 133:268-278).

AB - Context.-Many new therapies have emerged within the last 5 to 10 years to treat a variety of conditions. Several of these have direct or indirect renal toxicities that may go undiagnosed without careful attention of the pathologist to a patient's clinical history, particularly the addition of new medications or treatments. Objective.-To discuss patterns of renal injury resulting from medications or therapeutic regimens that have been introduced within the last 10 years. Recognition of these patterns may allow the pathologist to alert the attending clinician to a possible drug-induced renal injury and prevent further deterioration of renal function and possible chronic kidney disease. Data Sources.-A review of recent literature and unpublished observations of case-derived material. Conclusions.-A number of newer therapies have emerged as agents of renal toxicity, producing a variety of pathologic changes in the kidney. The outcome can be acute or chronic glomerular, tubular, interstitial, and/or vascular injury. Some drugs will result in irreversible changes and end-stage renal disease, whereas many of the alterations can be reversed with removal of the offending agent, avoiding potential long-term kidney injury. (Arch Pathol Lab Med. 2009; 133:268-278).

UR - http://www.scopus.com/inward/record.url?scp=59949084359&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=59949084359&partnerID=8YFLogxK

M3 - Article

C2 - 19195969

AN - SCOPUS:59949084359

VL - 133

SP - 268

EP - 278

JO - Archives of Pathology and Laboratory Medicine

JF - Archives of Pathology and Laboratory Medicine

SN - 0003-9985

IS - 2

ER -